March 5, 2013 -- Royal Philips Electronics, parent company of Philips Healthcare, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its EchoNavigator live image-guidance tool.
EchoNavigator helps interventional cardiologists and cardiac surgeons perform minimally invasive structural heart disease repairs by providing an integrated view of live x-ray and 3D ultrasound images, according to the firm.
EchoNavigator previously received the European CE Mark, and the first systems have already been installed in Europe and the U.S., Philips said.
Philips sales, profit climb in Q4, January 29, 2013
Philips wins contract in the Netherlands, December 26, 2012
Philips signs partnership with Southern Denmark region, December 21, 2012
Philips announces progress in dose reduction, December 18, 2012
Philips wins Bulgarian contract, December 12, 2012